HM Payson & Co’s Iterum Therapeutics ITRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $4 | Hold |
3
| – | – | ﹤0.01% | 1035 |
|
2024
Q4 | $6 | Hold |
3
| – | – | ﹤0.01% | 1033 |
|
2024
Q3 | $4 | Hold |
3
| – | – | ﹤0.01% | 1117 |
|
2024
Q2 | $4 | Hold |
3
| – | – | ﹤0.01% | 994 |
|
2024
Q1 | $5 | Hold |
3
| – | – | ﹤0.01% | 960 |
|
2023
Q4 | $6 | Hold |
3
| – | – | ﹤0.01% | 962 |
|
2023
Q3 | $3 | Hold |
3
| – | – | ﹤0.01% | 1000 |
|
2023
Q2 | $4 | Hold |
3
| – | – | ﹤0.01% | 994 |
|
2023
Q1 | $3 | Hold |
3
| – | – | ﹤0.01% | 1022 |
|
2022
Q4 | $3 | Hold |
3
| – | – | ﹤0.01% | 932 |
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1039 |
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1088 |
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1097 |
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1122 |
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1105 |
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1127 |
|
2021
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1150 |
|